Department of Medicine

Cholesterol

Vanderbilt doctors to screen patients taking statins for genetic risk factors

Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death.

Growth factor boosts beta cells

A growth factor may help grow transplantation-quality pancreas cells for treating diabetes.

Initiative to help ‘translate’ diabetes research advances

The new Center for Diabetes Translation Research will translate scientific breakthroughs into practices that can be applied in the doctor’s office and the patient’s home.

Operating Room

Predicting hospital readmission is risky business: study

Each year millions of Americans return to the hospital within 30 days of their previous discharge. Although many readmissions could be preventable, most statistical models for predicting them “perform poorly,” according to researchers at Vanderbilt and the Oregon Health and Science University and their affiliated VA medical centers.

Supplements don’t help lung injury patients

Supplements did not improve outcomes of patients with acute lung injury.

Heart protein may be target for colon cancer therapies

A protein critical in heart development may also play a part in colon cancer progression.

1 105 106 107 108 109 117